Moecks, J., Soulières, D., & Klughammer, B. (2015). ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer. J Pathol Clin Res.
Citação norma ChicagoMoecks, Joachim, Denis Soulières, and Barbara Klughammer. "ReadMax—a Novel Reading and Scoring Approach for EGFR Gene Copy Number to Predict Therapeutic Benefit of Erlotinib Treatment in EGFR Wild‐type Non‐small‐cell Lung Cancer." J Pathol Clin Res 2015.
MLA引文Moecks, Joachim, Denis Soulières, and Barbara Klughammer. "ReadMax—a Novel Reading and Scoring Approach for EGFR Gene Copy Number to Predict Therapeutic Benefit of Erlotinib Treatment in EGFR Wild‐type Non‐small‐cell Lung Cancer." J Pathol Clin Res 2015.